Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Natural killer (NK) cells are cytotoxic lymphocytes of the innate immune system that play a crucial role in tumor surveillance and viral defense. They recognize and kill target cells via a balance of activating and inhibitory receptor signals. Allogeneic NK cells, derived from a donor, can be used in cancer immunotherapy to overcome tumor evasion mechanisms and enhance anti-tumor activity. These cells mediate cytotoxicity through direct cell killing (perforin/granzyme release) and antibody-dependent cellular cytotoxicity (ADCC). They also secrete cytokines like IFN-γ to modulate the immune response.
NK cells recognize and kill target cells by releasing cytotoxic granules containing perforin and granzymes, inducing apoptosis. They are activated by a balance of activating and inhibitory receptor signals. Allogeneic NK cells exploit differences in KIR and HLA to enhance tumor cell recognition.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Natural Killer (NK) Cells (NK Cells).